ViroPharma's Cinryze granted European approval for hereditary HAE
16 June 2011
Pial Ganguli
Please Login to read the full article.
16 June 2011
Pial Ganguli
Please Login to read the full article.
RELATED CONTENT
NEWS
- Will Shire's acute HAE drug OK shift dynamic for ViroPharma's prophylactic?
- Pharming waterproofs cash liferaft as delays takes wind out of US Rhucin sales
- FDA panel backs Shire's Firazyr as self-administered acute HAE treatment
- US FDA declares Shire's Firazyr effective, safe for HAE ahead of panel
ANALYSIS
Other Informa Analysis
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
